MINI FUTURE SHORT - DIASORIN Stock

Certificat

P16LH1

NLBNPIT16LH1

Market Closed - Borsa Italiana 11:30:04 2022-03-01 am EST
61.1 ^EUR	+0.33%

1 month

+4.36%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart DIASORIN S.P.A.

Latest news about DIASORIN S.P.A.

Indices flat; Newlat runs after Princes acquisition.	May. 27	AN
Citadel Advisors moves on Saipem and Biesse.	May. 21	AN
DiaSorin takes over shares for more than EUR8 million	May. 20	AN
Ex-dividend day for final dividend	May. 19	FA

More news

Static data

Product type	Warrant Knock-Out con Stop Loss
Buy / Sell	PUT
Underlying	DIASORIN S.P.A.
Issuer	BNP Paribas
	P16LH1
ISIN	NLBNPIT16LH1
Date issued	2022-01-04
Strike	194.6 €
Maturity	2025-12-19 (570 Days)
Parity	1 : 1
Emission price	- €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	77.4 €
Lowest since issue	35.85 €

Company Profile

DiaSorin S.p.A. specializes in the development, manufacturing and marketing of in vitro diagnostic reagents. The products are used in treating infectious and viral diseases, thyroid pathologies, cancer, etc. At the end of 2023, the group had 10 production sites located in Italy, the United States (6), Canada, Germany, and the United Kingdom.

Sector

More about the company